Limitations to the use of ethylene oxide in the manufacture of medicinal products

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Reference numberEMEA/CVMP/271/01 Rev. 1
Effective from01/04/2001
KeywordsEthylene oxide, sterilisation, carcinogenic
DescriptionThis document describes the circumstances where sterilisation with ethylene oxide can be applied.

Document history

Revision 1

Current version

Adopted guideline

Concept paper

In operation: 01/04/2001–present (The revision 1 revises only the cover page of the note for guidance.  None of the text has been changed)

Published: 19/11/2015

First versionAdopted guidelineIn operation: 01/04/2001–present

Related content

How helpful is this page?

Average rating:

 Based on 32 ratings

Add your rating:

See all ratings
7 ratings
6 ratings
6 ratings
6 ratings
7 ratings

Tell us more